In the latest trading session, Hologic (HOLX) closed at $71.74, marking a -0.49% move from the previous day. The stock fell short of the S&P 500, which registered a loss of 0.22% for the day.

Evercore ISI lowered the firm’s price target on Hologic (HOLX) to $76 from $81 and keeps an In Line rating on the shares. In the firm’s 2025 ...

Shares of Hologic Inc. HOLX shed 0.49% to $71.74 Thursday, on what proved to be an all-around poor trading session for the ...

Hologic (HOLX) closed at $72.68 in the latest trading session, marking no change from the prior day. Hologic (HOLX) has been one of the stocks most watched by Zacks.com users lately. So, it is ...

12 analysts have shared their evaluations of Hologic HOLX during the recent three months, expressing a mix of bullish and bearish perspectives. The table below offers a condensed view of their ...

Hologic (HOLX) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term.

Valued at $16.5 billion by market cap, Hologic, Inc. (HOLX) is a global leader in the medical technology and diagnostics industry. Headquartered in Marlborough, Massachusetts, the company ...

Under CEO Stephen MacMillan's leadership, Hologic has been able to focus on structural competitive advantages, improve its balance sheet, and judiciously step into complementary markets ...

MARLBOROUGH, Mass.--(BUSINESS WIRE)--Hologic, Inc., (Nasdaq: HOLX) a global leader in women’s health focused on developing innovative medical technologies that effectively detect, diagnose and ...

https://www.tipranks.com/news/the-fly/anavex-price-target-raised-to-42-from-40-at-h-c-wainwright As previously reported, Wolfe Research analyst Doug Schenkel ...